Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Prostate Cancer
100%
Magnetic Resonance Imaging
76%
Malignant Neoplasm
39%
Adipose Tissue
34%
Positron Emission Tomography
33%
Diseases
27%
Computer Assisted Tomography
27%
Sex Differences
25%
Visceral Fat
24%
Multiparametric Magnetic Resonance Imaging
24%
Biopsy Technique
23%
Cancer
19%
Body Mass Index
19%
Overall Survival
18%
Cancer Cell
14%
Biological Marker
14%
Clear Cell Renal Cell Carcinoma
14%
Glycolysis
14%
Recurrent Disease
13%
Neoplasm
13%
Metabolic Pathway
13%
Glioblastoma
13%
Ganglioglioma
12%
Transgenic Mouse
12%
Metastatic Carcinoma
12%
Positron Emission Tomography-Computed Tomography
12%
Gamma-Aminobutyric Acid
11%
Polyethylene Terephthalate
11%
Tumor
11%
PI-RADS
11%
Uterine Cancer
11%
Proteomics
11%
Signal Transduction
10%
Castration Resistant Prostate Cancer
9%
Risk Stratification
9%
Prostate Specific Antigen
9%
Odds Ratio
9%
Magnetic Resonance Imaging of Prostate
8%
Alzheimer's Disease
8%
Solid Malignant Neoplasm
8%
Dosimetry
8%
Glucose
8%
Glucose Metabolism
7%
Subcutaneous Fat
7%
Glutamine
7%
Radiopharmaceutical
7%
Cell Metabolism
7%
Gene Expression Profiling
7%
Diagnostic Accuracy
7%
Carbon 11
7%
Keyphrases
Prostate Cancer
90%
Multiparametric Magnetic Resonance Imaging (mpMRI)
38%
Neuroendocrine Cancer
27%
Prostate
26%
Visceral Fat
24%
Positron Emission Tomography/computed Tomography (PET/CT)
24%
NCCN Guidelines
23%
Sex Differences
23%
Calcium Carbonate
22%
Tumor
20%
Aggressive Prostate Cancer
20%
Overall Survival
19%
Computed Tomography
19%
Metabolism
19%
Poor Prognosis
18%
Abdominal Adipose Tissue
17%
Renal Cell Carcinoma
16%
Body Composition
15%
Cardiac Magnetic Resonance Imaging (cMRI)
15%
Metabolic Pathways
14%
Cancer Genome Atlas
14%
N-glycan
13%
Abdominal Fat
13%
Neuroendocrine Cells
13%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
12%
Obesity
12%
PH-sensitive
12%
Sex-specific
12%
Metastasis
11%
Recurrent Disease
11%
Reporting System
11%
Cancer Metabolism
11%
Theranostic Platform
11%
Calcium Carbonate Nanoparticles
11%
Cocaine
11%
Acetylcholine Receptor (AChR)
11%
Nicotinic Acetylcholine Receptor (nAChR)
11%
Neuroendocrine Phenotype
11%
Bitter Melon Extract
11%
CCR2
11%
Diffusion Spectrum Imaging
11%
Midlife Obesity
11%
Patients with Prostate Cancer
11%
Ruptured Abdominal Aortic Aneurysm (rAAA)
11%
Data Systems
10%
Prostate Imaging Reporting
10%
95% Confidence Interval
10%
Image Interpretation
10%
Solid Tumors
10%
Body Mass Index
9%